| A Study to Evaluate the Effect of Itraconazole on Pharmacokinetics (PK) of SHR8554 in Healthy Adult Subjects (NCT05928988) | Jiangsu HengRui Medicine Co., Ltd. | 2022-01-04 |
| Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects (NCT04989829) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-27 |
| A Trial of HR17031 Injection With Hepatic Insufficiency (NCT05151705) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-20 |
| A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects (NCT05049083) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-17 |
| A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers (NCT05141422) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-13 |
| Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes (NCT05054842) | Jiangsu HengRui Medicine Co., Ltd. | 2021-12-06 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject (NCT05147259) | Jiangsu HengRui Medicine Co., Ltd. | 2021-11-26 |
| Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function (NCT05032235) | Jiangsu HengRui Medicine Co., Ltd. | 2021-11-09 |
| A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy (NCT05009290) | Jiangsu HengRui Medicine Co., Ltd. | 2021-11-01 |
| A Study of SHR6390 Combined With Famitinib in the Treatment of ER + / HER2- Advanced Breast Cancer (NCT05103826) | Jiangsu HengRui Medicine Co., Ltd. | 2021-10-25 |
| A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced Malignancies (NCT05048134) | Jiangsu HengRui Medicine Co., Ltd. | 2021-10-25 |
| A Trial of SHR-1703 in Asthma (NCT05042401) | Jiangsu HengRui Medicine Co., Ltd. | 2021-10-12 |
| SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma (NCT04948788) | Jiangsu HengRui Medicine Co., Ltd. | 2021-10-01 |
| A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT04985136) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-26 |
| A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer (NCT04995042) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-24 |
| Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects (NCT05046808) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-23 |
| A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis (NCT05074602) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-14 |
| Relative Bioavailability Study of HRG2010 in Healthy Subjects (NCT06976346) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-10 |
| A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. (NCT05016323) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-09 |
| A Study of Human Substance Balance and Biotransformation of [14C]SHR0302 (NCT05047341) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-07 |
| A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects (NCT05041920) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-07 |
| Pharmacokinetics of HR17031 Injection in Healthy Subjects (NCT05031871) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-02 |
| SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05020925) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-01 |
| A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers (NCT04973020) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-01 |
| To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis (NCT04957550) | Jiangsu HengRui Medicine Co., Ltd. | 2021-08-30 |
| A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects (NCT04991909) | Jiangsu HengRui Medicine Co., Ltd. | 2021-08-23 |
| Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors (NCT04979390) | Jiangsu HengRui Medicine Co., Ltd. | 2021-08-10 |
| Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia (NCT04885218) | Jiangsu HengRui Medicine Co., Ltd. | 2021-07-30 |
| Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer (NCT04906993) | Jiangsu HengRui Medicine Co., Ltd. | 2021-07-23 |
| A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer (NCT04869488) | Jiangsu HengRui Medicine Co., Ltd. | 2021-07-19 |
| To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects (NCT04945616) | Jiangsu HengRui Medicine Co., Ltd. | 2021-07-13 |
| A Trial of HR19042 Capsule in Healthy Chinese Subjects (NCT04887532) | Jiangsu HengRui Medicine Co., Ltd. | 2021-07-01 |
| Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single Arm, Open, Self-control) (NCT04850638) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-28 |
| A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer (NCT04718740) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-25 |
| A Bioequivalence Study of Hetrombopag in Healthy Subjects (NCT05088655) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-25 |
| A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout (NCT04956432) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-15 |
| Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General Anesthesia (NCT04867343) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-07 |
| A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer (NCT04884009) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-31 |
| A Trial of SHR0410 Injection for the Treatment of Pain After Endoscopic Surgery of the Lower Abdominal (NCT04852003) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-13 |
| A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation (NCT05015361) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-07 |
| SHR-1701 in Patients With Recurrent/Metastatic Scchn (NCT04650633) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-07 |
| A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects (NCT04862884) | Jiangsu HengRui Medicine Co., Ltd. | 2021-05-03 |
| Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative (NCT04842617) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-30 |
| Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis (NCT04839016) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-25 |
| A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis (NCT04956419) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-24 |
| A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer (NCT04818333) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-23 |
| Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage (NCT04849000) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-23 |
| Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer (NCT04862091) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-23 |
| A Clinical Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery (NCT04794738) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-18 |
| Effect of Fluconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects (NCT04850651) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-16 |
| SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research (NCT04844125) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-14 |
| HR021618 in Moderate to Severe Pain After Abdominal Surgery (NCT04811053) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-12 |
| A Study of Irinotecan Liposome in Advanced Pancreatic Cancer (NCT04796948) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-08 |
| A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NCT04842630) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-08 |
| A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer (NCT04680988) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-05 |
| A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation (NCT04639180) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-01 |
| A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors (NCT04513223) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-30 |
| Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia (NCT04737850) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-29 |
| The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes (NCT04799327) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-29 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects (NCT04802811) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-22 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT04691804) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-18 |
| A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors (NCT04679038) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-17 |
| Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects. (NCT04775615) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-17 |
| Study on the Bioavailability of SHR0302 in Healthy Subjects (NCT04712838) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-15 |
| Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease (NCT05841043) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-04 |
| A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery. (NCT04766463) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-03 |
| Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver Function (NCT04694365) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-01 |
| A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics (NCT04663282) | Jiangsu HengRui Medicine Co., Ltd. | 2021-02-04 |
| Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (NCT05515471) | Jiangsu HengRui Medicine Co., Ltd. | 2021-02-04 |
| An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants (NCT04631549) | Jiangsu HengRui Medicine Co., Ltd. | 2021-02-03 |
| A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC. (NCT04619433) | Jiangsu HengRui Medicine Co., Ltd. | 2021-02-01 |
| The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC. (NCT04691063) | Jiangsu HengRui Medicine Co., Ltd. | 2021-01-22 |
| A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC (NCT04699968) | Jiangsu HengRui Medicine Co., Ltd. | 2021-01-15 |
| Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride (NCT04621669) | Jiangsu HengRui Medicine Co., Ltd. | 2021-01-08 |
| Relative Bioavailability Study of SHR3680 (NCT04903158) | Jiangsu HengRui Medicine Co., Ltd. | 2021-01-06 |
| Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy (NCT04667143) | Jiangsu HengRui Medicine Co., Ltd. | 2021-01-01 |
| A Trial of HR021618 in Postsurgical Pain Management (NCT04699175) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-17 |
| A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer (NCT04425876) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-17 |
| Study to Investigate Relative Bioavailability of Different Formulations of SHR6390 in Healthy Subjects (NCT04667156) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-13 |
| A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (NCT04613674) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-09 |
| A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth. (NCT04812860) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-08 |
| A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC (NCT04603833) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-02 |
| Study on the Food Effects of Oral SHR4640 Tablets in Healthy Volunteers (NCT04620408) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-01 |
| An Investigational Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy Participants (NCT04631575) | Jiangsu HengRui Medicine Co., Ltd. | 2020-12-01 |
| Drug-Drug Interaction of SHR1459 With a Strong CYP3A Index Inducer (Rifampicin) (NCT04649723) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-24 |
| A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer (NCT04624217) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-24 |
| Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases. (NCT04470063) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-17 |
| A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects (NCT04457180) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-16 |
| Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A Inducer (NCT04680091) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-12 |
| Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers (NCT04616742) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-11 |
| A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC (NCT04580498) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-10 |
| A Trial of SHR1258 in Patients With Biliary Tract Cancer (NCT04571710) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-01 |
| A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients (NCT04517357) | Jiangsu HengRui Medicine Co., Ltd. | 2020-10-16 |
| A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis (NCT04481139) | Jiangsu HengRui Medicine Co., Ltd. | 2020-10-14 |
| Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers (NCT04586803) | Jiangsu HengRui Medicine Co., Ltd. | 2020-10-01 |
| A Trial of HR18034 in Inguinal Hernia Repair (NCT04551924) | Jiangsu HengRui Medicine Co., Ltd. | 2020-10-01 |
| A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects (NCT05088642) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-28 |
| Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC (NCT04342910) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-21 |
| Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations (NCT04688008) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-18 |
| Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib (NCT04409223) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-12 |